Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
NCT Number: NCT00065624
The goal of this study is to determine whether a short treatment with lipoic acid, an antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity and decreases oxidant stress in persons with elevated blood cholesterol.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Interventional
Phase 2
Nashville, Tennessee, 37232, United States
As per Brief Summary
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeNational Center for Complementary and Integrative Health (NCCIH)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05362903
Arterial Occlusive Diseases, Arteriosclerosis
Freudenstadt, Baden-Wurttemberg, Germany
View Trial DetailsNCT05952856
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias
Daphne, Alabama, United States
View Trial DetailsNCT00001154
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia
Bethesda, Maryland, United States
View Trial DetailsNCT06822621
Body Weight, Dyslipidemias
Athens, Attica, Greece
View Trial Details